Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Mayer Eldon C. III
Common stock purchase or sale:
Transaction
Date		Reported
DateTime		CompanySymbolInsider
Relationship		Shares
Traded		Average
Price		Total
Amount		Shares
Owned		Filing
2022-03-14
Sale		2022-03-14
9:21 pm		Eiger BioPharmaceuticals Inc.EIGRMayer Eldon C. III
Ex VP & Chief Commerc. Officer		1,657$5.5973$9,27560,468
(Direct)		View
2022-01-07
Sale		2022-01-11
8:59 pm		Eiger BioPharmaceuticals Inc.EIGRMayer Eldon C. III
Ex VP & Chief Commerc. Officer		1,560$4.9501$7,72246,125
(Direct)		View
2021-01-08
Sale		2021-01-11
6:10 pm		Eiger BioPharmaceuticals Inc.EIGRMayer Eldon C. III
Ex VP & Chief Commerc. Officer		1,690$11.68$19,73935,810
(Direct)		View
2020-01-24
Purchase		2020-01-30
4:44 pm		Eiger BioPharmaceuticals Inc.EIGRMayer Eldon C. III
Ex VP & Chief Commerc. Officer		5,000$13.52$67,60330,000
(Direct)		View
2018-11-29
Purchase		2018-11-30
2:26 pm		Eiger BioPharmaceuticals Inc.EIGRMayer Eldon C. III
Director		4,000$10.21$40,84025,000
(Direct)		View
2018-11-26
Purchase		2018-11-28
8:51 pm		Eiger BioPharmaceuticals Inc.EIGRMayer Eldon C. III
Director		21,000$9.9046$207,99821,000
(Direct)		View
2018-09-10
Purchase		2018-09-12
7:48 pm		RIGEL PHARMACEUTICALS INCRIGLMayer Eldon C. III
EVP & Chief Commercial Officer		100,000$3.2555$325,550215,000
(Direct)		View
2018-08-23
Purchase		2018-08-27
7:49 pm		RIGEL PHARMACEUTICALS INCRIGLMayer Eldon C. III
EVP & Chief Commercial Officer		100,000$2.8232$282,320115,000
(Direct)		View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date		Reported
DateTime		Exercisable
Expiration		CompanySymnbolInsider
Relationship		Shares
Traded		Conversion
Price		Shares
Owned		Filing
2023-01-26
Option Award		2023-01-30
9:25 pm		N/A
2033-01-26		Eiger BioPharmaceuticals Inc.EIGRMayer Eldon C. III
Ex VP & Chief Commerc. Officer		31,500$031,500
(Direct)		View
2022-03-11
Option Award		2022-03-11
9:06 pm		N/A
2032-03-10		Eiger BioPharmaceuticals Inc.EIGRMayer Eldon C. III
Ex VP & Chief Commerc. Officer		114,000$0160,125
(Direct)		View
2021-07-29
Option Award		2021-07-30
4:32 pm		N/A
2031-07-28		Eiger BioPharmaceuticals Inc.EIGRMayer Eldon C. III
Ex VP & Chief Commerc. Officer		17,500$017,500
(Direct)		View
2021-03-12
Option Award		2021-03-15
7:31 pm		N/A
2031-03-11		Eiger BioPharmaceuticals Inc.EIGRMayer Eldon C. III
Ex VP & Chief Commerc. Officer		83,125$0118,935
(Direct)		View
2020-01-31
Option Award		2020-01-31
7:33 pm		N/A
2030-01-30		Eiger BioPharmaceuticals Inc.EIGRMayer Eldon C. III
Ex VP & Chief Commerc. Officer		157,500$0187,500
(Direct)		View
2019-11-18
Option Award		2019-11-20
8:15 pm		N/A
2028-01-24		RIGEL PHARMACEUTICALS INCRIGLMayer Eldon C. III
EVP & Chief Commercial Officer		75,000$075,000
(Direct)		View
2019-03-21
Option Award		2019-03-25
10:00 pm		N/A
2029-03-20		Eiger BioPharmaceuticals Inc.EIGRMayer Eldon C. III
Director		10,000$010,000
(Direct)		View
2019-03-20
Option Award		2019-03-22
7:23 pm		N/A
2028-01-24		RIGEL PHARMACEUTICALS INCRIGLMayer Eldon C. III
EVP & Chief Commercial Officer		75,000$075,000
(Direct)		View
2019-01-23
Option Award		2019-01-25
6:36 pm		N/A
2029-01-23		RIGEL PHARMACEUTICALS INCRIGLMayer Eldon C. III
EVP & Chief Commercial Officer		200,000$0200,000
(Direct)		View
2018-05-09
Option Award		2018-05-11
7:47 pm		N/A
2027-02-02		RIGEL PHARMACEUTICALS INCRIGLMayer Eldon C. III
EVP & Chief Commercial Officer		50,000$050,000
(Direct)		View
2018-03-14
Option Award		2018-03-16
8:24 pm		N/A
2028-03-13		Eiger BioPharmaceuticals Inc.EIGRMayer Eldon C. III
Director		10,000$010,000
(Direct)		View